Connect to other sites within the UBM Medica Network
Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.
Follow Her on Twitter
Top 10 Highlights from ASCO 2015
This slide show highlights some of the top studies and news on cancer to come out of the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago.
Priority Review for MM-398 in Advanced Pancreatic Cancer
The FDA has granted a priority review for MM-398 as a second-line treatment for metastatic pancreatic cancer after the drug demonstrated improved survival.
Citrus Fruit Consumption May Up Risk of Melanoma
Frequent consumers of citrus fruits were found to have an elevated risk of malignant melanoma.
Cervical Cancer Screening Declines, Fewer Lesions Detected
Detection of cervical lesions among young women has decreased since the introduction of HPV vaccines and guidelines calling for reduced cervical cancer screening.
Erectile Dysfunction Medications Linked to Slight Risk of Melanoma
A study of men taking PDE5 inhibitors found a small but significant increase in the incidence of malignant melanoma, though the association may not be causal.
Blood Clots in Abdomen May Be Sign of Cancer
The presence of an abdominal blood clot may be a sign of cancer and may also be associated with poor survival for patients with pancreatic or liver cancers.
HPV Serum Antibodies Predict Survival in Oropharyngeal Cancer Patients
Detection of antibodies against HPV16 in the blood of patients with HPV-positive oropharyngeal carcinoma correlates with improved survival.
Uptick in Breast-Conserving Therapy, But Disparities Still Exist
Utilization of breast-conserving therapy has increased over the years in early breast cancer but there are still barriers, including socioeconomic factors.
PSA Screening for Prostate Cancer Declined in Men Over 50
PSA-based screening for prostate cancer among men older than 50 has decreased since the 2012 USPSTF recommendations.
No Difference in Efficacy for Three Bisphosphonates in Breast Cancer
A large randomized trial showed that three different bisphosphonates have similar efficacy in early-stage breast cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.